GEORGE WATHEN: Open Payments
NPI 1861453284 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 31 payments from 15 companies in 2025. Trend: 2023 $1,056 · 2024 $711 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $120 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| PFIZER INC. | 3 | $56 |
| Lilly USA, LLC | 2 | $53 |
| Tactile Systems Technology Inc | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Novo Nordisk Inc | 1 | $26 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
Products named: ELIQUIS, TRELEGY ELLIPTA, GEMTESA, MOUNJARO, Flexitouch Plus, TRINTELLIX, Rybelsus, NUPLAZID.
Industry payments across MD — which companies pay providers there.
